Found 6 matching trials
Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC NA The goal of this clinical trial is to evaluate the efficacy and safety of r...
Show More Location
Radiation Oncology Department, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC PHASE2 This is a prospective, single-arm, exploratory clinical study designed to e...
Show More Location
Tangdu Hospital Affiliated to the Fourth Military Medical University
Learn More & Join Trial
Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2) PHASE2 This is a single-center, single-arm, phase 2 trial evaluating the efficacy ...
Show More Location
Multiple Locations
Learn More & Join Trial
An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging PHASE2 This study will evaluate whether two positron emission tomography/computed ...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC PHASE2 Although phase III studies have confirmed the efficacy and safety of periop...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant SHR-A1811 and SHR-A1701 for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma PHASE1 This is a prospective, single-center, single-arm, phase Ib clinical study. ...
Show More Location
First Affiliated Hospital of Nanjing Medical Unviersity
Learn More & Join Trial